Anonymous ID: 755dc3 Dec. 8, 2021, 2:56 p.m. No.15160344   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>0479 >>0675

Hey, you!

Would you help me to carry the stone?

Open your heart, I'm coming home

 

But it was only fantasy.

The wall was too high as you can see.

No matter how he tried he could not break free.

And the worms ate into his brain.

 

Hey, you!

Out there on the road,

Always doing what you're told.

Can you help me?

Anonymous ID: 755dc3 Dec. 8, 2021, 3:43 p.m. No.15160574   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>0579

https://www.medscape.com/viewarticle/964382?fbclid=IwAR27Wlu55qz4IbDzkZk2U7RKUkW-OdJcvuTV3s5O9Fo2mDkkPExNanvuLvg

 

Today, there are two pills, Truvada (emtricitabine/tenofovir disoproxil fumarate, Gilead Sciences and generic) and Descovy (emtricitabine/tenofovir alafenamide, Gilead Sciences). The pills have been found to be up to 99% effective in preventing HIV acquisition. The new injectable cabotegravir appears to be even more effective.

The broadened guidance is part of an effort from the country's top health officials to expand PrEP prescribing from infectious disease specialists and sexual health clinics to healthcare professionals, including gynecologists, internal medicine physicians, and family practice clinicians. It appears to be necessary. In 2020, just 25% of the 1.2 million Americans who could benefit from PrEP were taking it, according to CDC data.

But those rates belie stark disparities in PrEP use by race and gender. The vast majority of those using PrEP are White Americans and men. Sixty-six percent of White Americans who could benefit from PrEP used it in 2020, and more than a quarter of the men who could benefit used it. By contrast, just 16% of Latinx people who could benefit had a prescription. And fewer than 1 in 10 Black Americans, who make up nearly half of those with indications for PrEP, had a prescription. The same was true for the women who could benefit.

Anonymous ID: 755dc3 Dec. 8, 2021, 3:44 p.m. No.15160579   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

>>15160574

 

Normalizing PrEP in Primary Care

 

When Courtney Sherman, DNP, APRN, first heard about PrEP in the early 2010s, she joked that her reaction was, "You're ridiculous. You're making that up. That's not real."

Today, Sherman is launching a tele-PrEP program from CAN Community Health, a nonprofit network of community health centers in southern Florida. The tele-PrEP program is meant to serve people in Florida and beyond, to increase access to the pill in areas with few healthcare professionals, or clinicians unwilling to prescribe it.

"When I go other places, I can't do what I do for a living without getting some sort of bizarre comment or look," she said. But the looks don't just come from family, friends, or her children's teachers. They come from colleagues, too. "What I've learned is that anybody โ€” anybody โ€” can be impacted [by HIV] and the illusion that 'those people who live over there do things that me and my kind don't do' is just garbage."

Anonymous ID: 755dc3 Dec. 8, 2021, 4:37 p.m. No.15160930   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

The Coronavirus Attacks Fat Tissue, Scientists Find

The research may help explain why people who are overweight and obese have been at higher risk of severe illness and death from Covidโ€ฆ.and it's behind a paywallโ€ฆas if there will be anything worth reading beyond this point.

 

https://www.nytimes.com/2021/12/08/health/covid-fat-obesity.html?fbclid=IwAR1nQE0MRmCOF9p_lNoG1twTOeEEp6wKdWuxjYyLOO14jSSa-N8_ETGzVuQ